Találati lista | Tudóstér

001-es BibID:	BIBFORM019242
Első szerző:	Laczik Renáta (orvos)
Cím:	Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome / Laczik, R., Szodoray, P., Veres, K., Szomjak, E., Csipo, I., Sipka, S. Jr., Shoenfeld, Y., Szekanecz, Z., Soltesz, P.
Dátum:	2011
ISSN:	0961-2033
Megjegyzések:	Circulating IgG antibodies to oxidized low-density lipoprotein (anti-oxLDL) have been implicated in the development of atherosclerotic plaques. In this study, we investigated the prognostic value of IgG anti-oxLDL antibodies in patients with acute coronary syndrome (ACS). Methods. In total 54 patients with ACS and 41 matched healthy controls were involved in this prospective study. Serum IgG anti-oxLDL levels were assessed by ELISA. Results. Higher IgG anti-oxLDL levels were found in patients with ACS versus controls (22.8 ± 23.3 vs. 7.5 ± 5.27 EU/ml, p < 0.0001). IgG anti-oxLDL concentrations were significantly higher in ACS patients with unstable clinical complications (circulatory insufficiency, malignant arrhythmias, recurring ischaemic pain, positive stress-test, need for urgent coronary intervention or sudden cardiac death) versus those without such complications (30.0 vs. 11.7 EU/ml, p < 0.001). Twelve patients (22%) were taking statins. Patients on statins had a significant reduction in clinical complications (33%) versus patients not receiving statin therapy (61%). IgG anti-oxLDL levels were also different in these two groups (11.4 vs. 25.8 EU/ml, respectively; p = 0.03). Serum IgG anti-oxLDL levels correlated with the subsequent development of unstable coronary events. Levels of anti-oxLDL significantly decreased in response to statin therapy, independently of its lipid-lowering effect. Conclusions. Anti-oxLDL antibodies are involved in ACS. The association of anti-oxLDL with unstable clinical complications may indicate the role of this antibody in plaque destabilization.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:	Lupus. - 20 : 7 (2011), p. 730-735. -
További szerzők:	Szodoray Péter (1973-) (belgyógyász, orvos) Veres Katalin (1971-) (orvos) Szomják Edit (1961-) (belgyógyász) Csípő István (1953-) (vegyész) Sipka Sándor ifj. (1980-) (orvos) Shoenfeld, Yehuda Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Soltész Pál (1961-) (belgyógyász, kardiológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM038846
Első szerző:	Szodoray Péter (belgyógyász, orvos)
Cím:	Distinct phenotypes in mixed connective tissue disease : subgroups and survival / P. Szodoray, A. Hajas, L. Kardos, B. Dezso, G. Soos, E. Zold, J. Vegh, I. Csipo, B. Nakken, M. Zeher, G. Szegedi, E. Bodolay
Dátum:	2012
ISSN:	0961-2033
Megjegyzések:	The aim of the present study was to assess the autoantibody profile, dominant clinical symptoms and cluster characteristics of different Mixed connective tissue disease (MCTD phenotypes. Two-hundred-and-one patients with MCTD were followed-up longitudinally. Five clinical parameters, Raynaud's phenomenon, pulmonary artery hypertension (PAH), myositis, interstitial lung disease (ILD), erosive arthritis and five auto-antibodies besides anti-U1RNP, antiendothelial cell antibodies (AECA), anti-CCP, anti-cardiolipin (anti-CL), anti-SSA/SSB and IgM rheumatoid factor (RF) were selected for cluster analysis. The mean age of patients was 52.9±12.4 years and the mean follow-up of the disease was 12.5±7.2 years. Patients were classified into three cluster groups. Cluster 1 with 77 patients, cluster 2 with 79 patients and cluster 3 with 45 patients. In cluster 1 the prevalence of PAH (55.8%; p<0.001), Raynaud's phenomenon (92.2%; p<0.001) and livedo reticularis (24.6%, p<0.001) was significantly greater than in cluster 2 and 3. In cluster 2, the incidence of ILD (98.7%; p<0.001), myositis (77.2%; p<0.001), and esophageal dysmotility (89.8%; p<0.001) was significantly greater than that in cluster 1 and 3. In cluster 3, anti-CCP antibodies were present in 31 of 45 patients (68.8%) with erosions. Anti-CCP antibodies were present in 37 of 42 patients (88.0%) with erosions. PAH, angina, venous thrombosis was observed in cluster 1 and pulmonary fibrosis in cluster 2, musculosceletal damage, gastrointestinal symptoms and osteoporotic fractures were most frequent in cluster 3. Cumulative survival assessment indicated cluster 1 patients having the worst prognosis. Cluster analysis is valuable to differentiate among various subsets of MCTD and useful prognostic factor regarding the disease course.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:	Lupus. - 21 : 13 (2012), p. 1412-1422. -
További szerzők:	Hajas Ágota Helga (1985-) (orvos) Kardos László (1970-) (megelőző orvostan és népegészségtan szakorvos) Dezső Balázs (1951-) (pathológus) Soós Györgyike (1959-) (pathológus) Zöld Éva (1978-) (belgyógyász) Végh Judit (1968-) (belgyógyász, kardiológus) Csípő István (1953-) (vegyész) Nakken, Britt Zeher Margit (1957-2018) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Szegedi Gyula (1936-2013) (belgyógyász, immunológus) Bodolay Edit (1950-) (belgyógyász, allergológus és klinikai immunológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: